results are consistent with this model, but in addition demonstrate that ongoing TCR triggering is required to sustain the signaling process. We have shown here that CD28 participates in the organization of the immune synapse by recruiting rafts into it (23). The fact that crosslinking of the rafts produced levels of costimulation comparable to that of CD28 engagement suggests that the costimulatory effect of CD28 in resting T cells is mediated to a large extent by its effect on raft redistribution.
pended by vortexing, and samples taken at different times were lysed. Anti-phosphotyrosine immunoblottings were performed as in (7) with anti-phosphotyrosine monoclonal antibody PY20 (Transduction Laboratories) for detection of phospho-LAT (12). In some experiments LAT was immunoprecipitated by a specific rabbit antibody (UBI) as described (26) . The immunoprecipitates were blotted with anti-phosphotyrosine, stripped, and reblotted with anti-LAT. 12. W. Zhang, J. Sloan-Lancaster, J. Kitchen, R. P. 5019 (1989) . T cells were stimulated with antibody-coated beads for various times at 37°C, settled onto poly-L-lysine-coated slides, fixed in 3.7% formaldehyde, stained with FITCCTx (Sigma, 8 g/ml), and analyzed by confocal microscopy. At least 50 conjugates were scored in each experiment. CTx staining was also measured by flow cytometric analysis by gating on living T cells conjugated with beads. Surface and total staining with FITC-CTx was performed on fresh and fixed and permeabilized cells (26). 19. T cells were stimulated in tissue culture wells that had been coated with anti-CD3 at various concentrations followed by addition of antibodies to CD28 (CD28.1), CD59 (p282, Pharmingen), MHC class I (W6/32) (all at 10 g/ml), or CTx (Sigma, 20 g/ml). 20. A. Kupfer and S. J. Singer, Annu. Rev. Immunol. 7, 309 (1989) Human HSCs are an attractive target for gene therapy of inherited hematopoietic disorders as well as other acquired disorders because these cells have the ability to regenerate the entire hematopoietic system. A number of in vitro assays have been established to detect pluripotent human hematopoietic cells (1) . However, these in vitro assays are unable to evaluate the long-term in vivo repopulating capacity that is a hallmark of HSCs. The NOD/SCID mouse (2) has been used to evaluate human HSCs in vivo (3) . CD34
ϩ primitive cells that have the capacity to initiate long-term multilineage engraftment in these mice have been operationally defined as SCID-repopulating cells (SRCs) (4) . Retroviral vectors, derived from oncoretroviruses such as the murine leukemia virus (MLV), have been the most widely used vectors for gene transfer because the vector genome integrates into the chromosomes of target cells, resulting in stable expression of transgenes (5) . Although retroviral vectors have proven efficient for transducing mouse HSCs, this finding has not been easily translatable to large animals or humans (6 ) . This lack of success possibly reflects the quiescent nature of human HSCs and the requirement of cell division for retroviral integration. Although retroviral transduction is efficient for human hematopoietic progenitor cells that have been stimulated to divide by cytokines, exposure to cytokines can lead to differentiation of the HSCs, possible loss of homing abilities, and probable reductions in longterm repopulating capacity (7).
We and others have developed HIV vectors that can transduce nondividing cells (8, 9) . The HIV vector was pseudotyped with the vesicular stomatitis virus G glycoprotein (VSV-G) to ensure a broad host range and facilitate concentration of virus to high titers. HIV vectors mediate efficient and stable transduction of postmitotic cells in brain, liver, muscle, and retina (8, 10) . Therefore, HIV vectors may facilitate the transduction of quiescent human HSCs. In this study, we evaluated whether HIV vectors could transfer genes into human CD34 ϩ cells that provide for long-term repopulation of NOD/SCID mice. CD34 ϩ cells were isolated from human umbilical cord blood and maintained in serum-free medium before transduction (11). To minimize cycling and to maintain the in vivo repopulating capability, we transduced CD34 ϩ cells by means of a simple protocol in the absence of any exogenous cytokines. CD34 ϩ cells were transduced for 5 hours with VSV-G-pseudotyped HIV vector that contained the green fluorescent protein (GFP) gene under the control of the internal cytomegalovirus (CMV) promoter at a multiplicity of infection (MOI) of 60 or 300 (12). For comparison, VSV-G-pseudotyped MLV vector containing the same CMV-GFP expression cassette was used.
Transduction efficiencies were first assessed by in vitro assays. A portion of transduced CD34 ϩ cells was cultured for 5 days in serumfree medium containing recombinant human stem cell factor (SCF), interleukin-3 (IL-3), and ϩ cells in methylcellulose with cytokines (14). GFP ϩ CFC colonies, including burst-forming unit-erythroid (BFU-E), colony-forming unit-granulocyte, macrophage (CFU-GM), CFU-granulocyte, erythroid, macrophage, megakaryocyte (CFU-GEMM), and high proliferative potential-CFC (HPP-CFC) colonies, were scored by fluorescence microscopy at days 14 and 21. The number of GFP ϩ CFC colonies transduced with the HIV vector was 12-fold higher at an MOI of 60 (12 Ϯ 1%) and eightfold higher at an MOI of 300 (17 Ϯ 3%) than that of GFP ϩ CFC colonies transduced with the MLV vector. These results indicate that the HIV vector was more efficient than the MLV vector for transduction of CD34 ϩ progenitors that generate CFCs. No adverse effect of transduction on cell viability and proliferation was observed in these in vitro assays.
To assess the transduction efficiency of SRCs in the CD34 ϩ cell population, we transplanted transduced CD34 ϩ cells into sublethally irradiated NOD/SCID mice (15). Mice were serially bled from 7 to 22 weeks after transplantation to monitor GFP ϩ human cells in the peripheral blood (PB). The percentage of GFP ϩ human cells in the PB was determined by two-color flow cytometry (16 ). Most mice showed high levels of human cells in the PB, and the majority (Ն95%) of these human cells were CD19 ϩ B cells, reflecting the dominance of B cell lymphopoiesis in this model (17) . Representative results shown in Fig. 1 demonstrate that CD34 ϩ cells transduced with the HIV vector gave rise to GFP ϩ human cells in the PB of engrafted mice and that the proportion of GFP ϩ human cells remained roughly constant until the animals were killed. GFP ϩ human cells were present in the PB for up to 22 weeks (see Table 1 ), the longest engraftment time period analyzed, demonstrating sustained production of human cells with integrated vector. In contrast, none of the mice (n ϭ 6) transplanted with MLV vector-transduced CD34 ϩ cells had detectable GFP ϩ human cells in the PB (Fig. 1 ), although these mice had numbers of human cells in the PB similar to those of mice transplanted with HIV vector-transduced CD34 ϩ cells. GFP expression in human myeloid and lym- ϩ cells. CFC colonies derived from BM cells of engrafted mice were analyzed by fluorescence microscopy. GFP ϩ BFU-E, CFU-GM, and HPP-CFC colonies are shown. Original magnifications were ϫ25 for BFU-E and ϫ12.5 for CFU-GM and HPP-CFC. Mean Ϯ SE ¶:
phoid lineages in the bone marrow (BM) and spleen of engrafted mice was evaluated at various time points after transplantation (16). High levels of human cell engraftment were evident in the BM of most of the mice (see Table 1 
CD34
ϩ cells were detected, suggesting that immature GFP ϩ cells were maintained in the BM. The results from three separate experiments are summarized in Table 1 . These results document the presence of GFP ϩ human cells in the BM (range 1 to 27%), spleen (range 3 to 22%), and PB (range 2 to 20%) of all mice (n ϭ 14) transplanted with HIV vector-transduced CD34 ϩ cells. There was no substantial difference between an MOI of 60 and 300. On the other hand, no GFP ϩ human cells were detected in all mice (n ϭ 6) transplanted with MLV vector-transduced CD34 ϩ cells. In addition, polymerase chain reaction (PCR) analysis of genomic DNA from BM cells revealed the presence of the GFP gene only in the BM cells from mice transplanted with HIV vector-transduced CD34 ϩ cells (Fig. 3A) . To determine the percentages of GFP ϩ myeloid and erythroid progenitors in the BM of engrafted mice, we performed CFC assays in methylcellulose cultures that only support outgrowth of human progenitors (14). As shown in Fig. 3C , multiple lineages of human CFC colonies, including BFU-E, CFU-GM, and HPP-CFC colonies, derived from BM cells of mice transplanted with HIV vector-transduced CD34 ϩ cells expressed GFP (range 3 to 77%) (see Table 1 ). The presence of the GFP gene in the GFP ϩ CFC colonies was verified by PCR analysis of randomly selected colonies (Fig.  3B) . In contrast, no GFP ϩ CFC colonies were detected from mice transplanted with MLV vector-transduced CD34 ϩ cells, further confirming the flow cytometric analysis of PB, BM, and spleen cells.
To address whether HIV vector integration correlated with GFP expression, we randomly isolated individual GFP Ϫ CFC colonies and analyzed them by PCR for the presence of the GFP gene (18) . Although there were some GFP Ϫ colonies containing the GFP gene (Fig. 3B) , the majority of GFP Ϫ colonies did not contain the GFP gene (see Table 1 ). Thus, a large proportion of CFCs transduced with the HIV vector did express the GFP at a level detectable by fluorescence microscopy. On the basis of the results from fluorescence microscopy and PCR analysis of CFC colonies, the average percentage of transduction of CFC colonies from mice transplanted with HIV vector-transduced CD34 ϩ cells was 38 Ϯ 7% (range 12 to 74%) at an MOI of 60 and 28 Ϯ 13% (range 4 to 90%) at an MOI of 300 (Table 1) . These results, together with data from PB longitudinal studies, demonstrated that the CMV promoter in the HIV vector can function properly in differentiated myeloid, erythroid, and lymphoid human cells with little silencing. The lack of expression of GFP in CFC colonies containing the GFP gene may have resulted from positional effects of the proviral integration site. Alternatively, these colonies expressed GFP at levels not detectable by fluorescence microscopy. HIV vector-mediated transduction had no adverse effect on human cell engraftment in NOD/SCID mice or colony-forming ability of progenitor cells as compared with mock transduction.
On the basis of human transplantation studies, human HSCs are known to be included in the CD34 ϩ cell population. A number of groups have provided strong evidence that the Lin
Ϫ cell subpopulation contains SRCs, and it has been proposed that this subpopulation contains HSCs (3). It has also been shown that SRCs were transduced by retroviral vectors only when cytokine prestimulation was used (19) 
Ϫ cell population also has long-term repopulating capacity and may be a precursor of Lin Ϫ
ϩ HSCs (21) . Therefore, it would be of interest to determine whether HIV vectors can transduce these Lin Ϫ
Ϫ cells and possibly confirm the proposed role of these cells in the hierarchy of the hematopoietic system. Finally, a potential problem for the application of HIV vectors to human studies is safety. In this regard, recent improvements, including self-inactivating vectors, packaging constructs eliminating all accessory genes, and inducible packaging cell lines, could further minimize the risk (22) . The use of HIV vectors provides a previously unexplored basis for the study of hematopoiesis and for human gene therapy with the use of HSCs. 11. Cord blood was obtained at the Scripps Memorial
Hospital from infants with uncompromised deliveries. Mononuclear cells were obtained from cord blood as previously described [B. Reinhardt et al., AIDS Res. Hum. Retroviruses 10, 131 (1994) ]. CD34 ϩ cells were isolated from cord blood mononuclear cells with a VarioMACS device (Miltenyi Biotec, Auburn, CA) according to the manufacturer's instructions. After isolation, CD34 ϩ cells were resuspended at a concentration of 4.5 ϫ 10 6 cells/ml in serum-free medium. Serum-free medium was composed of Iscove's modified Dulbecco's medium (Life Technologies, Gaithersburg, MD) supplemented with 10% BIT 9500 serum substitute (Stem Cell Technologies, Vancouver, Canada). The purity of CD34 ϩ cells was Ͼ95% as determined by flow cytometry. 12. The HIV and MLV vectors used in this study and preparation of viral vector stocks have been described (10) . Briefly, the VSV-G-pseudotyped HIV vector was generated by transient cotransfection of the vector construct pHRЈ-CMV-GFP (15 g) with the VSV-G-expressing construct pMD.G (5 g) and the packaging construct pCMV⌬R8.2 (10 g) into 293T cells. The VSV-G-pseudotyped MLV vector was generated by the same procedure as the HIV vector except with the vector construct pCLNCG and 293 gp/bsr cells that stably express MLV gag and pol. High-titer viral vector stocks were prepared by ultracentrifugation. The titers of viral vectors were determined by infection of 293T cells. 1.2 ϫ 10 6 CD34 ϩ cells maintained in serum-free medium for 24 hours were transduced with each viral vector at an MOI of 60 or 300 in a total volume of 0.9 ml for 5 hours at 37°C in 5% CO 2 . Transduced CD34 ϩ cells were washed with serum-free medium and then used for in vitro assays and reconstitution of NOD/SCID mice. 13. 2 ϫ 10 4 transduced or mock-transduced CD34 ϩ cells/ ml were incubated in serum-free medium containing the following recombinant human cytokines: SCF (100 ng/ml), IL-3 (50 ng/ml), and IL-6 (50 U/ml). Half of the medium was replaced every 2 days, and the transduction efficiency was determined by flow cytometry of GFP expression in the FL-1 channel at day 5. 14. For the CFC assay, 500 CD34 ϩ cells or total BM cells from engrafted mice containing 500 human CD34 ϩ cells, as determined by flow cytometry, were plated in triplicate 35-mm dishes with methylcellulose cultures containing the following recombinant human cytokines: SCF (50 ng/ml), IL-3 (10 ng/ml), granulocyte macrophage colony-stimulating factor (10 ng/ml), and erythropoietin (3 U/ml) (Stem Cell Technologies). These conditions support only the growth of human progenitor cells. Total and GFP ϩ CFC colonies were counted under an inverted fluorescence microscope (Zeiss). BFU-E, CFU-GM, and CFU-GEMM colonies were counted at day 14, and HPP-CFC colonies were counted at day 21 on the basis of morphological criteria. 15. 2.0 to 3.5 ϫ 10 5 transduced or mock-transduced CD34 ϩ cells were transplanted by tail-vein injection into sublethally irradiated (300 centigrays by 137 Cs ␥-irradiation) 8-to 10-week-old NOD/SCID mice. 16. Mononuclear cells were isolated from PB, BM, and
